中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
The Development of Inhibitors Targeting the Mixed Lineage Leukemia 1 (MLL1)-WD Repeat Domain 5 Protein (WDR5) Protein-Protein Interaction

文献类型:期刊论文

作者Ye, Xiaoqing2,3; Chen, Gang1; Jin, Jia3; Zhang, Binzhong1; Wang, Yinda1; Cai, Zhenhai1; Ye, Fei3
刊名CURRENT MEDICINAL CHEMISTRY
出版日期2020
卷号27期号:33页码:5530-5542
关键词WDR5 MLL1 histone methyltransferase small-molecular inhibitor epigenetics human acute leukemia
ISSN号0929-8673
DOI10.2174/0929867326666190528080514
通讯作者Ye, Fei(yefei@zstu.edu.cn)
英文摘要Mixed Lineage Leukemia 1 (MLL1), an important member of Histone Methyltransferases (HMT) family, is capable of catalyzing mono-, di-, and trimethylation of Histone 3 lysine 4 (H3K4). The optimal catalytic activity of MLL1 requires the formation of a core complex consisting of MLL1, WDR5, RbBP5, and ASH2L. The Protein-Protein Interaction (PPI) between WDR5 and MLL1 plays an important role in abnormal gene expression during tumorigenesis, and disturbing this interaction may have a potential for the treatment of leukemia harboring MLL1 fusion proteins. In this review, we will summarize recent progress in the development of inhibitors targeting MLL1-WDR5 interaction.
WOS关键词H3K4 METHYLTRANSFERASE ACTIVITY ; STRUCTURE-BASED DESIGN ; AIDED DRUG DESIGN ; HISTONE H3 ; MOLECULAR RECOGNITION ; STRUCTURAL BASIS ; HIGH-AFFINITY ; SET1 FAMILY ; MLL PROTEIN ; COMPLEX
资助项目Natural Science Foundation of Zhejiang Province[LY18H300008] ; National Natural Science Foundation of China[81803339]
WOS研究方向Biochemistry & Molecular Biology ; Pharmacology & Pharmacy
语种英语
WOS记录号WOS:000580568500004
出版者BENTHAM SCIENCE PUBL LTD
源URL[http://119.78.100.183/handle/2S10ELR8/291486]  
专题新药研究国家重点实验室
通讯作者Ye, Fei
作者单位1.Jiaxing Univ, Affiliated Hosp 2, Jiaxing, Peoples R China
2.Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai, Peoples R China
3.Zhejiang Sci Tech Univ, Coll Life Sci & Med, Hangzhou, Peoples R China
推荐引用方式
GB/T 7714
Ye, Xiaoqing,Chen, Gang,Jin, Jia,et al. The Development of Inhibitors Targeting the Mixed Lineage Leukemia 1 (MLL1)-WD Repeat Domain 5 Protein (WDR5) Protein-Protein Interaction[J]. CURRENT MEDICINAL CHEMISTRY,2020,27(33):5530-5542.
APA Ye, Xiaoqing.,Chen, Gang.,Jin, Jia.,Zhang, Binzhong.,Wang, Yinda.,...&Ye, Fei.(2020).The Development of Inhibitors Targeting the Mixed Lineage Leukemia 1 (MLL1)-WD Repeat Domain 5 Protein (WDR5) Protein-Protein Interaction.CURRENT MEDICINAL CHEMISTRY,27(33),5530-5542.
MLA Ye, Xiaoqing,et al."The Development of Inhibitors Targeting the Mixed Lineage Leukemia 1 (MLL1)-WD Repeat Domain 5 Protein (WDR5) Protein-Protein Interaction".CURRENT MEDICINAL CHEMISTRY 27.33(2020):5530-5542.

入库方式: OAI收割

来源:上海药物研究所

浏览0
下载0
收藏0
其他版本

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。